STOCK TITAN

Village Farms International Announces Pure Sunfarms' Receipt of EU GMP Certification

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Village Farms International announced that its subsidiary, Pure Sunfarms, received EU GMP certification for its Delta 3 cannabis facility in British Columbia. This certification allows the company to export medical cannabis to EU markets, particularly targeting Germany, the largest medical cannabis market in the EU, with shipments expected to commence in Q3 2022. The certification is seen as a pivotal step in the company's strategy to expand its international cannabis platform and explore additional markets, including Israel.

Positive
  • EU GMP certification obtained for Delta 3 facility enables export of medical cannabis to EU.
  • First shipments to Germany expected in Q3 2022, creating a new revenue stream.
  • Expansion of production capabilities with the new Delta 2 facility.
Negative
  • None.

 EU GMP Certification Permits Pure Sunfarms to Export Cannabis Products to EU Medical Markets – First Shipments Targeted for Third Quarter 2022 –

VANCOUVER, BC, March 9, 2022 /PRNewswire/ - Village Farms International, Inc. ("Village Farms" or the "Company") (NASDAQ: VFF) today announced its wholly owned subsidiary, Pure Sunfarms, has received EU GMP certification from Bezirksregierung Düsseldorf (District Government of Dusseldorf, Germany) for its 1.1 million square foot Delta 3 cannabis production facility located in Delta, British Columbia.  EU GMP certification permits Pure Sunfarms to export EU GMP-certified medical cannabis to importers and distributors in international markets that require EU GMP certification.

"Our ability to now export our cannabis products to the EU and other international markets that require EU GMP certification provides an incremental revenue stream in addition to the strong growth that we continue to expect in Canada in 2022 and beyond," said Mandesh Dosanjh, President and Chief Executive Officer, Pure Sunfarms.  "We look forward to providing the EU high quality, British Columbia-grown medical cannabis flower, beginning in the largest medical cannabis market in the region, Germany, with shipments to that country targeted to begin in the third quarter of this year."

"Pure Sunfarms' receipt of EU GMP certification marks another major step forward in Village Farms' strategy to build a world-class, international cannabis platform," said Michael DeGiglio, President and Chief Executive Officer, Village Farms.  "In addition to the expected near-term growth from this expansion, we believe existing medical markets in the EU, and elsewhere, are a pathway to participating in much larger legal recreational cannabis opportunities as these markets develop."

Mr. DeGiglio, added, "We also continue to advance our plans for Pure Sunfarms to export cannabis to Israel, with sales anticipated to start there by the end of this year."

In anticipation of receipt of EU GMP certification for the Delta 3 facility, as well as other growth initiatives and opportunities for 2022, in late 2021 Pure Sunfarms expanded its overall capacity, commencing production in the first half of its second 1.1 million square foot greenhouse facility, Delta 2. In addition, Pure Sunfarms staff previously underwent GMP education and training to align production at Delta 3 with EU GMP standards.

Germany, with a population of more than 83 million, more than 90% of which are covered by public health insurers, is the largest legal medical cannabis market in the EU.

About Village Farms International, Inc.

Village Farms leverages decades of experience as a large-scale, Controlled Environment Agriculture-based, vertically integrated supplier for high-value, high-growth plant-based Consumer Packaged Goods opportunities, with a strong foundation as a leading fresh produce supplier to grocery and large-format retailers throughout the US and Canada, and new high-growth opportunities in the cannabis and CBD categories in North America and selected markets internationally.

In Canada, the Company's wholly-owned Canadian subsidiary, Pure Sunfarms, is one of the single largest cannabis operations in the world, the lowest-cost greenhouse producer and one of Canada's best-selling brands. The Company also owns 70% of Québec-based, Rose LifeScience, a leading third-party cannabis products commercialization expert in the Province of Québec.

In the US, wholly-owned Balanced Health Botanicals is one of the leading CBD brands and e-commerce platforms in the country.  Subject to compliance with all applicable US federal and state laws and stock exchange rules, Village Farms plans to enter the US high-THC cannabis market via multiple strategies, leveraging one of the largest greenhouse operations in the country (more than 5.5 million square feet in West Texas), as well as the operational and product expertise gained through Pure Sunfarms' cannabis success in Canada.

Internationally, Village Farms is targeting selected, nascent, legal cannabis and CBD opportunities with significant medium- and long-term potential, with an initial focus on the Asia-Pacific region and Europe.

Cautionary Statement Regarding Forward-Looking Information

This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and is subject to the safe harbor created by those sections. This press release also contains "forward-looking information" within the meaning of applicable Canadian securities law. We refer to such forward-looking statements and forward-looking information collectively as "forward-looking statements". Forward-looking statements include statements regarding the Company's future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, expansion plans, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, the greenhouse vegetable industry or the cannabis industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as "can", "outlook", "may", "might", "will", "could", "should", "would", "occur", "expect", "plan", "anticipate", "believe", "intend", "try", "estimate", "predict", "potential", "continue", "likely", "schedule", "objectives", or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. The forward-looking statements in this press release are subject to risks that may include, but are not limited to: our operating history, Pure Sunfarms; the legal status of Pure Sunfarms cannabis business; risks relating to obtaining additional financing, including our dependence upon credit facilities; potential difficulties in achieving and/or maintaining profitability; variability of product pricing; risks inherent in the cannabis, hemp, CBD, cannabinoids, and agricultural businesses; market position, ability to leverage current business relationships for future business involving hemp and cannabinoids, the ability of Pure Sunfarms to cultivate and distribute cannabis in Canada; existing and new governmental regulations, including risks related to regulatory compliance and regarding obtaining and maintaining licenses required under the Cannabis Act (Canada), the Criminal Code and other Acts, S.C. 2018, c. 16 (Canada) for its Canadian operational facilities), and changes in our regulatory requirements; legal and operational risks relating to expected conversion of our greenhouses to cannabis production in Canada and in the United States; risks related to rules and regulations at the US federal (Food and Drug Administration and United States Department of Agriculture), state and municipal levels with respect to produce and hemp, cannabidiol-based products commercialization; retail consolidation, technological advances and other forms of competition; transportation disruptions; product liability and other potential litigation; retention of key executives; labor issues; uninsured and underinsured losses; vulnerability to rising energy costs; environmental, health and safety risks, foreign exchange exposure, risks associated with cross-border trade; difficulties in managing our growth; restrictive covenants under our credit facilities; natural catastrophes; the ongoing and developing COVID-19 pandemic; and tax risks.

The Company has based these forward-looking statements on factors and assumptions about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs. Although the forward-looking statements contained in this press release are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company's control, that may cause the Company's or the industry's actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company's filings with securities regulators, including this press release. In particular, we caution you that our forward-looking statements are subject to the ongoing and developing circumstances related to the COVID-19 pandemic, which may have a material adverse effect on our business, operations and future financial results.

When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this press release relate only to events or information as of the date on which the statements are made in this press release. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

Cision View original content:https://www.prnewswire.com/news-releases/village-farms-international-announces-pure-sunfarms-receipt-of-eu-gmp-certification-301498916.html

SOURCE Village Farms International, Inc.

FAQ

What is the significance of VFF's EU GMP certification?

The EU GMP certification allows Village Farms' subsidiary, Pure Sunfarms, to export medical cannabis to EU markets, particularly Germany, enhancing revenue opportunities.

When will Village Farms start shipping cannabis to Germany?

Shipments of cannabis to Germany are targeted to begin in the third quarter of 2022.

How does the EU GMP certification impact VFF's business strategy?

The certification marks a significant step in Village Farms' strategy to build a global cannabis platform, facilitating entry into lucrative international markets.

Which markets is VFF planning to enter with its cannabis products?

Village Farms plans to export cannabis to the EU, particularly Germany, and anticipates starting sales in Israel by the end of 2022.

Village Farms International, Inc. Common Shares

NASDAQ:VFF

VFF Rankings

VFF Latest News

VFF Stock Data

90.50M
112.34M
10.15%
17.77%
2.06%
Farm Products
Consumer Defensive
Link
United States of America
LAKE MARY